A novel malnutrition assessment model predicts the inflammatory storm of relapsed/refractory acute myeloid leukemia following C-type lectin-like molecule-1 chimeric antigen receptor T therapy. The gene discussed is CLEC12A; the disease is acute myeloid leukemia.